EVERYTHING YOU EVER WANTED TO KNOW ABOUT OBESITY MEDICATIONS

OMR to publish annual drugs in development issue.

September 29,1999. OMR's ANNUAL DRUGS IN DEVELOPMENT ISSUE will be on-line the third week of October. This is our most popular edition of the year where we review drugs still in the creation stage, some of which will be available in a few years some 10 years down the road. Some subscribers refer to this issue as OMR's Sports Illustrated swimsuit edition. We won't have any pictures of women in bikinis in this month, but you will gain some valuable information on medications coming out in the next few years that will put you or your patients on the road to a healthier life -- and maybe even that swimsuit!

All the articles in this month's edition will concern the development of new anti-obesity drugs and news on existing medications. If you want to know when leptin, thermogenic medications, and gene therapy treatments will be available this issue is a must!

As part of this year's focus on giving you "news you can use" in October we will also bring you an exclusive article by Dr. Richard B. Rothman, a researcher and expert on psychotropic drugs who also practices bariatric medicine. Dr. Rothman has been using an exclusive formula in his practice that he says works almost as well as fenfluramine. Find out what it is, and how your doctor can prescribe it to you in

October OMR!

A main feature of this yearly edition is our DRUGS IN DEVELOPMENT CALENDAR which gives

readers an overview of all anorectic medications being created including, information on the pharmaceutical company developing the drug, the stage in development, how it works, and lots more.

In addition to all the above, you will learn what drug companies are forming new partnerships on obesity medications, and which ones are changing their focus to anorectic medication development.

If you're interested in new weight loss medications, you'll have it here in one easy to read issue next month. Only in OBESITY MEDS AND RESEARCH NEWS.

See some of our other press releases under "Medical".

Contact information: Barbara Hirsch, Publisher, OBESITY MEDS AND RESEARCH NEWS, PO Box 19316, Alexandria, VA 22320- 0316, telephone: 703/960-3649; fax: 703/960-7462; e-mail: subscriptions@obesity-news.com. OMR is available in both on-line and hard copy editions.